Detection of chronic obstructive pulmonary disease in primary care in Salzburg, Austria: Findings from the real world

Respiration

Volumn 87, Issue 2, 2014, Pages 136-143

  Weiss, Gertraud ^a   Steinacher, Ina ^a   Lamprecht, Bernd ^a   Schirnhofer, Lea ^a   Kaiser, Bernhard ^a   Sönnichsen, Andreas ^b   Studnicka, Michael ^a  

^a University Clinic of Pneumology   (Austria)

^b PARACELSUS MEDICAL UNIVERSITY   (Austria)

Author keywords

Airway obstruction; Chronic obstructive pulmonary disease; Epidemiology; Primary care; Spirometry

Indexed keywords

SALBUTAMOL;

ADULT; AIRWAY OBSTRUCTION; ARTICLE; AUSTRIA; BRONCHODILATATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE SEVERITY; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GENERAL PRACTITIONER; HEALTH CARE PRACTICE; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; PREVALENCE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RANDOM SAMPLE; SPIROMETRY; MIDDLE AGED; PRIMARY HEALTH CARE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; STATISTICS AND NUMERICAL DATA;

AUSTRIA; FEMALE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; PRIMARY HEALTH CARE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SPIROMETRY;

EID: 84894505001     PISSN: 00257931     EISSN: 14230356     Source Type: Journal    
DOI: 10.1159/000354796     Document Type: Article

References (40)

1. Murray CJL, Lopez AD: Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 1997; 349: 1498-1504.
2. Firlei N, Lamprecht B, Schirnhofer L, Kaiser B, Studnicka M: Die Prävalenz der COPD in Österreich-die erwartete Entwicklung bis 2020. Wien Klin Wochenschr 2007; 119: 513-518.
3. Buist AS, McBurnie MA, Vollmer WM, Gillespie S, Burney P, Mannino DM, Menezes AM, Sullivan SD, Lee TA, Weiss KB, Jensen RL, Marks GB, Gulsvik A, Nizankowska-Mogilnicka E, BOLD Collaborative Research Group: International variation in the prevalence of COPD (the BOLD study): a population based prevalence study. Lancet 2007; 370: 741-750.
4. Menezes AM, Perez-Padilla R, Jardim JR, Muiño A, Lopez MV, Valdivia G, Montes de Oca M, Talamo C, Hallal PC, Victora CG, PLATINO Team: Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study. Lancet 2005; 366:1875-1881.
5. Wouters EF: COPD: a chronic and overlooked pulmonary disease. Lancet 2007; 370: 715-716.
6. Enright PL, Studnicka M, Zielinski J: Spirometry to detect and manage COPD and asthma in the primary care setting. Eur Respir Mon 2005; 31: 1-14.
7. Lamprecht B, Mahringer A, Soriano JB, Kaiser B, Buist AS, Studnicka M: Is spirometry properly used to diagnose COPD? Results from the BOLD study in Salzburg, Austria: a population-based analytical study. Prim Care Respir J 2013; 22: 195-200.
8. Enright P: Should we keep pushing for a spirometer in every doctor's office? Respir Care 2012; 57: 146-151.
9. Buffels J, Degryse J, Liistro G, Decramer M: Differential diagnosis in a primary care population with presumed airway obstruction: a real-life study. Respiration 2012; 84: 44-54.
10. Qaseem A, Wilt TJ, Weinberger SE, Hanania NA, Criner G, van der Molen T, Marciniuk DD, Denberg T, Schünemann H, Wedzicha W, MacDonald R, Shekelle P: Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society. Ann Intern Med 2011; 155: 179-191.
11. Petty TL, Doherty DE, National Lung Health Education Program: The National Lung Health Education Program: roots, mission, future directions. Respir Care 2004; 49: 678-683.
12. Ferguson GT, Enright PL, Buist AS, Higgins MW: Office spirometry for lung health assessment in adults: a consensus statement from the National Lung Health Education Program. Chest 2000; 117: 1146-1161.
13. Schirnhofer L, Lamprecht B, Vollmer W, Allison MJ, Studnicka M, Jensen RL, Buist AS: COPD prevalence in Salzburg, Austria: results from the Burden of Obstructive Lung Disease (BOLD) Study. Chest 2007; 131: 29-36.
14. Kinnula VL, Vasankari T, Kontula E, Sovijarvi A, Saynajakangas O, Pietinalho A: The 10-year COPD Programme in Finland: effects on quality of diagnosis, smoking, prevalence, hospital admissions and mortality. Prim Care Respir J 2011; 20: 178-183.
15. Koopmans B, Mark MJ, Schellevis NFG, Korevaar JC: Non-participation in populationbased disease prevention programs in general practice. BMC Public Health DOI: 10.1186/1471-2458-12-856.
16. American Thoracic Society Statement: Standardization of spirometry, 1994 update. Am J Respir Crit Care Med 1995; 152: 1107-1136.
17. Buist AS, Vollmer WM, Sullivan SD, Weiss KB, Lee TA, Menezes AM, Crapo RO, Jensen RL, Burney PG: The Burden of Obstructive Lung Disease Initiative (BOLD): rationale and design. COPD 2005; 2: 277-283.
18. Global Initiative for Chronic Obstructive Lung Disease: Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. http://www. goldcopd.com (accessed October 17, 2012).
19. Hankinson JL, Odencrantz JR, Fedan KB: Spirometric reference values from a sample of the general US population. Am J Respir Crit Care Med 1999; 159: 179-187.
20. National Institutes of Health: COPD awareness continues to rise, new NIH survey finds. 2011, http://www.nih.gov/news/health/nov2011/nhlbi-21.htm (accessed October 17, 2012).
21. Nowak P, Geißler W, Holzer U, Knauer C: Themenqualitätsbericht COPD. Band 1 der Bereichsreihe Fokus Qualität. Wien, Bundesministerium für Gesundheit, 2013.
22. U.S. Preventive Services Task Force: Screening for chronic obstructive pulmonary disease using spirometry: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2008; 148: 529-534.
23. Bednarek M, Maciejewski J, Wozniak M, Kuca P, Zielinski J: Prevalence, severity and underdiagnosis of COPD in the primary care setting. Thorax 2008; 63: 402-407.
24. Carre PC, Roche N, Neukirch F, Radeau T, Perez T, Terrioux P, Ostinelli J, Pouchain D, Huchon G: The effect of an information leaflet upon knowledge and awareness of COPD in potential sufferers. A randomized controlled study. Respiration 2008; 76: 53-60.
25. Schirnhofer L, Lamprecht B, Firlei N, Kaiser B, Buist AS, Halbert RJ, Allison MJ, Studnicka M: Using targeted spirometry to reduce nondiagnosed chronic obstructive pulmonary disease. Respiration 2011; 81: 476-482.
26. Hamers R, Bontemps S, van den Akker M, Souza R, Penaforte J, Chavannes N: Chronic obstructive pulmonary disease in Brazilian primary care: diagnostic competence and casefinding. Prim Care Respir J 2006; 15: 299-306.
27. van Schayck CP, Loozen JMC, Wagena E, Akkermans RP, Wesseling GJ: Detecting patients at a higher risk of developing chronic obstructive pulmonary disease in general practices: cross sectional case finding study. BMJ 2002; 324: 1370.
28. Walters JA, Hansen EC, Johns DP, Blizzard EL, Walters EH, Wood-Baker R: A mixed methods study to compare models of spirometry delivery in primary care for patients at risk of COPD. Thorax 2008; 63: 408-414.
29. Labeit AM, Klotsche J, Pieper L, Pittrow D, Einsle F, Stalla GK, Lehnert H, Silber S, Zeiher AM, Marz W, Wehling M, Wittchen HU: Changes in the prevalence, treatment and control of hypertension in Germany? A clinical-epidemiological study of 50.000 primary care patients. PLoS One 2012; 7:e52229.
30. Bosner S, Haasenritter J, Keller H, Abu Hani M, Sonnichsen AC, Baum E, Donner-Banzhoff N: The diagnosis of coronary heart disease in a low-prevalence setting: follow-up data from patients whose CHD was misdiagnosed by their family doctors. Dtsch Arztebl Int 2011; 108: 445-451.
31. O'Neill SM, Rubinstein WS, Wang C, Yoon PW, Acheson LS, Rothrock N, Starzyk EJ, Beaumont JL, Galliher JM, Ruffin MT 4th, Family Healthware Impact Trial group: Familial risk for common diseases in primary care: the Family Healthware Impact Trial. Am J Prev Med 2009; 36: 506-514.
32. Sheehy AM, Benca J, Glinberg SL, Li Z, Nautiyal A, Anderson PA, Squire MW, Coursin DB: Preoperative 'NPO' as an opportunity for diabetes screening. J Hosp Med 2012; 7: 611-616.
33. Price DB, Tinkelman DG, Halbert RJ, Nordyke RJ, Isonaka S, Nonikov D, Juniper EF, Freeman D, Hausen T, Levy ML, Ostrem A, van der Molen T, van Schayck CP: Symptombased questionnaire for identifying COPD in smokers. Respiration 2006; 73: 285-295.
34. Enright P, Vollmer WM, Lamprecht B, Jensen R, Jithoo A, Tan W, Studnicka M, Burney P, Gillespie S, Buist AS: Quality of spirometry tests performed by 9893 adults in 14 countries: the BOLD Study. Respir Med 2011; 105: 1507-1515.
35. Schermer TR, Jacobs JE, Chavannes NH, Hartman J, Folgering HT, Bottema BJ, van Weel C: Validity of spirometric testing in a general practice population of patients with chronic obstructive pulmonary disease (COPD). Thorax 2003; 58: 861-866.
36. Leuppi JD, Miedinger D, Chhajed PN, Buess C, Schafroth S, Bucher HC, Tamm M: Quality of spirometry in primary care for case finding of airway obstruction in smokers. Respiration 2010; 79: 469-474.
37. Ferguson GT, Enright PL, Buist AS, Higgins MW: Office spirometry for lung health assessment in adults: a consensus statement from the National Lung Health Education Program. Chest 2000; 117: 1146-1161.
38. Takahasthi T, Ichinose M, Inoue H, Shirato K, Hattori T, Takishima T: Underdiagnosis and undertreatment of COPD in primary care settings. Respirology 2003; 8: 504-508.
39. Fukuchi Y, Nishimura M, Ichinose M, Adachi M, Nagai A, Kuriyama T, Takahashi K, Nishimura K, Ishioka S, Aizawa H, Zaher C: COPD in Japan: the Nippon Epidemiology study. Respirology 2004; 9: 458-465.
40. Miller MR, Hankinson J, Brusasco V, et al: Standardisation of spirometry. Eur Respir J 2005; 26: 319-338.